Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2887 (107th)

Best Pharmaceuticals for Children Act

openUnited States· United States Congress· EN

Introduced

13 September 2001

Last action

16 November 2001 · Introduced

Status

Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 228.

Sponsors

Rep. Greenwood, James C. [R-PA-8], Rep. Eshoo, Anna G. [D-CA-18], Rep. Upton, Fred [R-MI-6], Rep. Wynn, Albert Russell [D-MD-4], Rep. Buyer, Steve [R-IN-4], Rep. Rush, Bobby L. [D-IL-1], ROBERT BRADY, Rep. Roybal-Allard, Lucille [D-CA-40], Rep. Lofgren, Zoe [D-CA-18], Rep. Roukema, Marge [R-NJ-5], Rep. Smith, Christopher H. [R-NJ-4], Rep. Rangel, Charles B. [D-NY-15], Rep. Frank, Barney [D-MA-4], Rep. Fattah, Chaka [D-PA-2], Rep. Woolsey, Lynn C. [D-CA-6], Rep. Whitfield, Ed [R-KY-1], Rep. Owens, Major R. [D-NY-11], Rep. Morella, Constance A. [R-MD-8], Rep. Dooley, Calvin M. [D-CA-20], Rep. McGovern, James P. [D-MA-2], Rep. Lantos, Tom [D-CA-12], Rep. Capuano, Michael E. [D-MA-8], Rep. Kind, Ron [D-WI-3]

Subjects

Healthcare

Source updated

7 April 2025

Healthcare

Summary

Best Pharmaceuticals for Children Act - Amends the Public Health Service Act to direct the Secretary of Health and Human Services, through the National Institutes of Health, to develop an annual list of approved drugs for which: (1) there is an approved or pending new drug application or no patent or market exclusivity protection; and (2) additional pediatric safety and effectiveness studies are needed. Directs the Secretary to award contracts to entities with appropriate experience for pediatric clinical trials of such drugs. Establishes a Food and Drug Administration (FDA) contract process for related labeling changes. Amends the Federal Food, Drug, and Cosmetic Act to: (1) eliminate the user fee waiver for pediatric supplements to a human drug application; (2) provide priority status for pediatric supplements; (3) include neonates within the definition of pediatric studies; (4) provide for dissemination of pediatric supplement information; and (5) set forth requirements for the additional six-month exclusivity period for new or already-marketed pediatric drugs. Directs the Secretary to establish an Office of Pediatric Therapeutics within the Office of the Commissioner of Food and Drugs, which shall coordinate all FDA pediatric activities. Amends Title IV of the Public Health Service Act to direct the Secretary to establish the Foundation for Pediatric Research to support research on drugs lacking exclusivity for which pediatric studies are needed. Directs the Secretary to contract with the Institute of Medicine to review Federal regulations, reports, and support for research involving children, with particular attention to issues of compensation, informed consent, and risk/ benefits assessments in terms of research versus therapeutic treatment.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 13 September 2001

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 13 September 2001

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 13 September 2001

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 27 September 2001

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  5. 5 October 2001

    Vote

    Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 24 - 5.

    Source: Committee

  6. 5 October 2001

    Committee

    Subcommittee Consideration and Mark-up Session Held.

    Source: Committee

  7. 11 October 2001

    Vote

    Ordered to be Reported (Amended) by the Yeas and Nays: 41 - 6.

    Source: Committee

  8. 11 October 2001

    Committee

    Committee Consideration and Mark-up Session Held.

    Source: Committee

  9. 9 November 2001

    Reported

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 107-277.

    Source: Committee

  10. 9 November 2001

    Calendars

    Placed on the Union Calendar, Calendar No. 167.

    Source: Calendars

  11. 9 November 2001

    Reported

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 107-277.

    Source: Committee

  12. 13 November 2001

    Vote

    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

    Source: Floor

  13. 13 November 2001

    Floor

    DEBATE - The House proceeded with forty minutes of debate on H.R. 2887.

    Source: Floor

  14. 13 November 2001

    Floor

    Considered under suspension of the rules. (consideration: CR H8094-8107)

    Source: Floor

  15. 13 November 2001

    Floor

    Mr. Tauzin moved to suspend the rules and pass the bill, as amended.

    Source: Floor

  16. 15 November 2001

    Passed

    Motion to reconsider laid on the table Agreed to without objection.

    Source: Floor

  17. 15 November 2001

    Vote

    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 338 - 86 (Roll no. 444). (text: CR 11/13/2001 H8094-8098)

    Source: Floor

  18. 15 November 2001

    Vote

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 338 - 86 (Roll no. 444).(text: CR 11/13/2001 H8094-8098)

    Source: Floor

  19. 15 November 2001

    Floor

    Considered as unfinished business. (consideration: CR H8216)

    Source: Floor

  20. 16 November 2001

    Introduced

    Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 228.

    Source: Calendars

Votes

No vote records are attached yet.

Versions

Documents

11 official files

Placed on Calendar Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Placed on Calendar Senate (text)

    Placed on Calendar Senate · EN · 16 November 2001

    ViewDownloadOpen at official source

  • Placed on Calendar Senate (PDF)

    Placed on Calendar Senate · EN · 16 November 2001

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Engrossed in House (text)

    Engrossed in House · EN · 15 November 2001

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Engrossed in House (PDF)

    Engrossed in House · EN · 15 November 2001

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Passed House amended

    summary · EN · 15 November 2001

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Reported in House (text)

    Reported in House · EN · 9 November 2001

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Reported in House (PDF)

    Reported in House · EN · 9 November 2001

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Reported to House with amendment(s)

    summary · EN · 9 November 2001

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 13 September 2001

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (PDF)

    Introduced in House · EN · 13 September 2001

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 13 September 2001

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.